Oh, oh. The National Institutes of Health just released a study that found 20 to 42% of all malaria drugs in Southeast Asia and Sub-Saharan Africa are of poor quality or are fake. Here's the press release
. This obviously has large potential implications for staff safety in areas where malaria is prevalent.